Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Joint statement on the use of flukicides in dairy cattle
'When prescribing, it is important to be aware of the withdrawal period requirements'

Document contains a summary of the various products available.

A joint statement on the use of flukicides in dairy cattle has been released by the National Office of Animal Health (NOAH) and the Veterinary Medicines Directorate (VMD).

Flukicides are anthelmintic veterinary medicines that are active against parasites from the trematode class. The most common parasite in this class is the liver fluke.

The statement reads: 'Vets, Suitably Qualified Persons (SQPs) and farmers are generally required to follow the instructions on the product labels; however, the prescribing decision rests with the vet, pharmacist or SQP.

'When prescribing, it is important to be aware of withdrawal period requirements specified on the labels and farmers should follow the advice given by the vet or the SQP.'

The statement also contains a summary of the various dairy cattle flukticides products authorised for sale in the UK.

Because some of the products place restrictions on the use of the product depending on the stage of pregnancy, users and prescribers are urged to consider this information carefully when treating animals. 

The full document can be read here.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.